Oral High-Dose Medroxyprogesterone Acetate (MPA) Treatment: Cortisol/MPA Serum Profiles in Relation to Breast Cancer Regression

M. Mahlke,H.J. Grill,P. Knapstein,U. Wiegand,K. Pollow

Oral High-Dose Medroxyprogesterone Acetate (MPA) Treatment: Cortisol/MPA Serum Profiles in Relation to Breast Cancer Regression

1985

M. Mahlke
H.J. Grill
P. Knapstein
U. Wiegand
K. Pollow

Medroxyprogesterone acetate (MPA), a potent synthetic progestin, has been widely used in the hormonal treatment of advanced breast cancer, but presently with varying dose schedules. The availability o

Keywords:

Breast cancer
Medicine
Medroxyprogesterone acetate
Endocrinology
Internal medicine
Progestin
Metastatic breast cancer
Medroxyprogesterone
Cancer
Radioimmunoassay
Hormone
Hydrocortisone

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations